Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Z011972 | — |
late shipment; was told by shipper Sanofi product was not viable and marked "do not use". Product was administered to 3 patients; no additional AE; late shipment; was told by shipper Sanofi product was not viable and marked "do not use". Product was administered to 3 patients; This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 02-Dec-2025, the patient was vaccinated with Hepatitis A Vaccine, Inactivated (VAQTA), Suspension for injection (lot #Z011972, expiration date: 13-Oct-2026; reconstituted with sterile diluent Solution for injection) which was not viable and marked "do not use". Because this was a late shipment, storage and temperature conditions were unknown. No additional adverse event was reported. This is one of 3 reports received from the same reporter.
sterile diluent (with device)